The idea that retinol thins your skin likely comes from some of the short-term side effects it causes when you first start ...

Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in ...

- Cash Position: Cash and cash equivalents were $101.6 million as of March 31, 2025, compared to $34.6 million as of December 31, 2024, bolstered by $76.4 million in gross proceeds from the first ...

Cognition Therapeutics has announced positive topline outcomes from the Phase II MAGNIFY trial of zervimesine in adult ...

Palatin Technologies, Inc. (OTC PINK: PTNT), a biopharmaceutical company advancing innovative treatments targeting the melanocortin receptor system, today announced new preclinical data on its ...

The world’s largest beauty company is said to have emerged as the front-runner to buy the U.K.-based skin care brand.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Pham, who’s accused of violating the Federal Food, Drug, and Cosmetic Act, has pleaded guilty to a federal charge: receipt in ...

Prolonged screen time and lack of natural light are among factors that have led to a global increase in this condition among ...

Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...

Regenxbio has received a total of 8 ratings from analysts, with the consensus rating as Buy. With an average one-year price ...

Findings highlight PL9654 and PL9655's potential to treat diabetic retinopathy through inflammation resolution, vascular stabilization, and neuroprotection PL9654 ...